Articles
| Open Access |
DOI: Improving The Principles Of Treatment In Patients With Zoonotic Leishmaniasis With The Immunomodulator Gepon And Methylene Blue Using The Alt Vostok Apparatus
Rakhmatov Olim Bobomurodovich , Bukhara State Medical Institute, Uzbekistan Khushvaktova Madina Farkhodovna , Bukhara State Medical Institute, UzbekistanAbstract
The object of the study was 102 patients with zoonotic leishmaniasis aged 2 to 65 years. The diagnosis of zoonotic leishmaniasis was established by clinical and epidemiological data and confirmed by the results of parasitological studies.
We studied the duration of the clinical periods of zoonotic leishmaniasis against the background of complex therapy with methylene blue using the ALT Vostok apparatus in the control group of 51 patients and complex therapy with methylene blue using the ALT Vostok apparatus and the immunomodulator Gepon in the main group of 51 patients. The results of the study showed that in patients of the main group, on the background of treatment with the ALT Vostok apparatus using the immunomodulator Gepon, the duration of the main periods was significantly reduced than in the control group, who were treated only with methylene blue using the ALT Vostok model-03 apparatus.
Keywords
Leishmaniasis, methylene blue,, ALT Vostok model-03 apparatus
References
Weekly epidemiological record of WHO 2018.
Dzhalilova N.A., 2014.
Dudchenko M.I. et al., 2002.
HIV peptides.1998. Rupert, H.
Silin D.S., Lyubomskaya O.V., Ershov, F.I., Frolov V.M., Kutsyna, 2009.
Khaitov R.M., Pinegin B.V., 2001.
Ataullakhanov R.I., Holmes R.D., Narovlyansky A.N. et al., 2002.
Article Statistics
Copyright License
Copyright (c) 2021 The American Journal of Medical Sciences and Pharmaceutical Research
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain the copyright of their manuscripts, and all Open Access articles are disseminated under the terms of the Creative Commons Attribution License 4.0 (CC-BY), which licenses unrestricted use, distribution, and reproduction in any medium, provided that the original work is appropriately cited. The use of general descriptive names, trade names, trademarks, and so forth in this publication, even if not specifically identified, does not imply that these names are not protected by the relevant laws and regulations.